“Our third quarter results reflect the strength of our international strategy, and the resilience of our differentiated business model” said David Pidduck, CEO of MediPharm Labs (MEDIF). “MediPharm is uniquely positioned to serve the most complex and highest value medical cannabis markets worldwide with a range of direct to patient, partnership and distribution pathways.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDIF: